Do analysts recommend KEQU or PRE?

Prenetics Global has a consensus target price of $34.25, indicating a potential upside of 82.11%. Given Prenetics Global's stronger consensus rating and higher probable upside, analysts clearly believe Prenetics Global is more favorable than Kewaunee Scientific. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kewaunee Scientific 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Prenetics Global 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60

Do analysts recommend LAB or KEQU?

Standard BioTools presently has a consensus target price of $1.35, suggesting a potential upside of 51.35%. Given Standard BioTools' higher probable upside, equities research analysts clearly believe Standard BioTools is more favorable than Kewaunee Scientific. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Standard BioTools 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Kewaunee Scientific 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts recommend OPTX or KEQU?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Syntec Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Kewaunee Scientific 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts rate KEQU or MASS?

908 Devices has a consensus price target of $11.50, indicating a potential upside of 41.50%. Given 908 Devices' stronger consensus rating and higher probable upside, analysts plainly believe 908 Devices is more favorable than Kewaunee Scientific. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kewaunee Scientific 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 908 Devices 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Do analysts rate NAUT or KEQU?

Nautilus Biotechnology currently has a consensus target price of $4.00, indicating a potential upside of 308.16%. Given Nautilus Biotechnology's higher probable upside, equities analysts plainly believe Nautilus Biotechnology is more favorable than Kewaunee Scientific. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nautilus Biotechnology 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Kewaunee Scientific 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Kewaunee Scientific (KEQU) Competitors

$36.56 +0.84 (+2.34%)

Closing price 07/31/2026 07:34 PM Eastern

Extended Trading

$36.56 0.00 (0.00%)

As of 07/31/2026 07:34 PM Eastern

Compare

KEQU vs. PRE, LAB, OPTX, MASS, and NAUT

Should you buy Kewaunee Scientific stock or one of its competitors? MarketBeat compares Kewaunee Scientific with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Kewaunee Scientific include Prenetics Global (PRE), Standard BioTools (LAB), Syntec Optics (OPTX), 908 Devices (MASS), and Nautilus Biotechnology (NAUT).

How does Kewaunee Scientific compare to Prenetics Global?

Kewaunee Scientific (NASDAQ:KEQU) and Prenetics Global (NASDAQ:PRE) are related small-cap companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings.

Kewaunee Scientific has a beta of 0.72, indicating that its share price is 28% less volatile than the broader market. Comparatively, Prenetics Global has a beta of 0.26, indicating that its share price is 74% less volatile than the broader market.

Kewaunee Scientific has higher revenue and earnings than Prenetics Global. Prenetics Global is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kewaunee Scientific	$282M	0.37	$9.62M	$3.22	11.35
Prenetics Global	$92.39M	3.43	-$37.71M	-$4.58	N/A

Kewaunee Scientific has a net margin of 3.41% compared to Prenetics Global's net margin of -62.45%. Kewaunee Scientific's return on equity of 14.10% beat Prenetics Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kewaunee Scientific	3.41%	14.10%	5.55%
Prenetics Global	-62.45%	-20.33%	-15.42%

Prenetics Global has a consensus target price of $34.25, indicating a potential upside of 82.11%. Given Prenetics Global's stronger consensus rating and higher probable upside, analysts clearly believe Prenetics Global is more favorable than Kewaunee Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kewaunee Scientific	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

In the previous week, Prenetics Global had 1 more articles in the media than Kewaunee Scientific. MarketBeat recorded 1 mentions for Prenetics Global and 0 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 0.00 equaled Prenetics Global'saverage media sentiment score.

Company	Overall Sentiment
Kewaunee Scientific	Neutral
Prenetics Global	Neutral

32.7% of Kewaunee Scientific shares are owned by institutional investors. Comparatively, 25.0% of Prenetics Global shares are owned by institutional investors. 14.1% of Kewaunee Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Kewaunee Scientific beats Prenetics Global on 10 of the 15 factors compared between the two stocks.

How does Kewaunee Scientific compare to Standard BioTools?

Standard BioTools (NASDAQ:LAB) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and media sentiment.

Standard BioTools presently has a consensus target price of $1.35, suggesting a potential upside of 51.35%. Given Standard BioTools' higher probable upside, equities research analysts clearly believe Standard BioTools is more favorable than Kewaunee Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Standard BioTools	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Kewaunee Scientific	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Kewaunee Scientific has higher revenue and earnings than Standard BioTools. Standard BioTools is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Standard BioTools	$85.33M	4.08	-$74.90M	$0.20	4.46
Kewaunee Scientific	$282M	0.37	$9.62M	$3.22	11.35

53.7% of Standard BioTools shares are held by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are held by institutional investors. 26.8% of Standard BioTools shares are held by company insiders. Comparatively, 14.1% of Kewaunee Scientific shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Standard BioTools had 3 more articles in the media than Kewaunee Scientific. MarketBeat recorded 3 mentions for Standard BioTools and 0 mentions for Kewaunee Scientific. Standard BioTools' average media sentiment score of 0.62 beat Kewaunee Scientific's score of 0.00 indicating that Standard BioTools is being referred to more favorably in the media.

Company	Overall Sentiment
Standard BioTools	Positive
Kewaunee Scientific	Neutral

Standard BioTools has a net margin of 73.46% compared to Kewaunee Scientific's net margin of 3.41%. Kewaunee Scientific's return on equity of 14.10% beat Standard BioTools' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Standard BioTools	73.46%	-8.18%	-6.43%
Kewaunee Scientific	3.41%	14.10%	5.55%

Standard BioTools has a beta of 1.39, meaning that its share price is 39% more volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.72, meaning that its share price is 28% less volatile than the broader market.

Summary

Standard BioTools beats Kewaunee Scientific on 8 of the 15 factors compared between the two stocks.

How does Kewaunee Scientific compare to Syntec Optics?

Syntec Optics (NASDAQ:OPTX) and Kewaunee Scientific (NASDAQ:KEQU) are related small-cap companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.

Kewaunee Scientific has a net margin of 3.41% compared to Syntec Optics' net margin of -10.95%. Kewaunee Scientific's return on equity of 14.10% beat Syntec Optics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Syntec Optics	-10.95%	-30.86%	-12.35%
Kewaunee Scientific	3.41%	14.10%	5.55%

Syntec Optics has a beta of -0.86, meaning that its share price is 186% less volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.72, meaning that its share price is 28% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Syntec Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Kewaunee Scientific	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

32.7% of Kewaunee Scientific shares are owned by institutional investors. 0.8% of Syntec Optics shares are owned by company insiders. Comparatively, 14.1% of Kewaunee Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Kewaunee Scientific has higher revenue and earnings than Syntec Optics. Syntec Optics is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Syntec Optics	$27.53M	10.08	-$1.79M	-$0.08	N/A
Kewaunee Scientific	$282M	0.37	$9.62M	$3.22	11.35

In the previous week, Syntec Optics had 4 more articles in the media than Kewaunee Scientific. MarketBeat recorded 4 mentions for Syntec Optics and 0 mentions for Kewaunee Scientific. Syntec Optics' average media sentiment score of 0.64 beat Kewaunee Scientific's score of 0.00 indicating that Syntec Optics is being referred to more favorably in the media.

Company	Overall Sentiment
Syntec Optics	Positive
Kewaunee Scientific	Neutral

Summary

Kewaunee Scientific beats Syntec Optics on 11 of the 14 factors compared between the two stocks.

How does Kewaunee Scientific compare to 908 Devices?

Kewaunee Scientific (NASDAQ:KEQU) and 908 Devices (NASDAQ:MASS) are related small-cap companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, media sentiment, risk, profitability, analyst recommendations and dividends.

Kewaunee Scientific has a beta of 0.72, meaning that its share price is 28% less volatile than the broader market. Comparatively, 908 Devices has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market.

908 Devices has lower revenue, but higher earnings than Kewaunee Scientific. 908 Devices is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kewaunee Scientific	$282M	0.37	$9.62M	$3.22	11.35
908 Devices	$57.80M	5.32	$19.49M	-$1.00	N/A

In the previous week, 908 Devices had 6 more articles in the media than Kewaunee Scientific. MarketBeat recorded 6 mentions for 908 Devices and 0 mentions for Kewaunee Scientific. 908 Devices' average media sentiment score of 0.73 beat Kewaunee Scientific's score of 0.00 indicating that 908 Devices is being referred to more favorably in the news media.

Company	Overall Sentiment
Kewaunee Scientific	Neutral
908 Devices	Positive

32.7% of Kewaunee Scientific shares are owned by institutional investors. Comparatively, 88.1% of 908 Devices shares are owned by institutional investors. 14.1% of Kewaunee Scientific shares are owned by insiders. Comparatively, 28.2% of 908 Devices shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Kewaunee Scientific has a net margin of 3.41% compared to 908 Devices' net margin of -62.40%. Kewaunee Scientific's return on equity of 14.10% beat 908 Devices' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kewaunee Scientific	3.41%	14.10%	5.55%
908 Devices	-62.40%	-14.03%	-10.40%

908 Devices has a consensus price target of $11.50, indicating a potential upside of 41.50%. Given 908 Devices' stronger consensus rating and higher probable upside, analysts plainly believe 908 Devices is more favorable than Kewaunee Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kewaunee Scientific	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
908 Devices	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

908 Devices beats Kewaunee Scientific on 9 of the 16 factors compared between the two stocks.

How does Kewaunee Scientific compare to Nautilus Biotechnology?

Nautilus Biotechnology (NASDAQ:NAUT) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and profitability.

Kewaunee Scientific has a net margin of 3.41% compared to Nautilus Biotechnology's net margin of 0.00%. Kewaunee Scientific's return on equity of 14.10% beat Nautilus Biotechnology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nautilus Biotechnology	N/A	-37.58%	-30.83%
Kewaunee Scientific	3.41%	14.10%	5.55%

Nautilus Biotechnology has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.72, indicating that its share price is 28% less volatile than the broader market.

Nautilus Biotechnology currently has a consensus target price of $4.00, indicating a potential upside of 308.16%. Given Nautilus Biotechnology's higher probable upside, equities analysts plainly believe Nautilus Biotechnology is more favorable than Kewaunee Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nautilus Biotechnology	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Kewaunee Scientific	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Kewaunee Scientific has higher revenue and earnings than Nautilus Biotechnology. Nautilus Biotechnology is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nautilus Biotechnology	$10K	12,470.99	-$59M	-$0.45	N/A
Kewaunee Scientific	$282M	0.37	$9.62M	$3.22	11.35

In the previous week, Nautilus Biotechnology had 8 more articles in the media than Kewaunee Scientific. MarketBeat recorded 8 mentions for Nautilus Biotechnology and 0 mentions for Kewaunee Scientific. Nautilus Biotechnology's average media sentiment score of 1.06 beat Kewaunee Scientific's score of 0.00 indicating that Nautilus Biotechnology is being referred to more favorably in the media.

Company	Overall Sentiment
Nautilus Biotechnology	Positive
Kewaunee Scientific	Neutral

50.7% of Nautilus Biotechnology shares are held by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are held by institutional investors. 41.1% of Nautilus Biotechnology shares are held by company insiders. Comparatively, 14.1% of Kewaunee Scientific shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Nautilus Biotechnology beats Kewaunee Scientific on 8 of the 15 factors compared between the two stocks.

Get Kewaunee Scientific News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KEQU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

KEQU vs. The Competition

Export

Metric	Kewaunee Scientific	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$104.91M	$5.58B	$6.85B	$12.42B
Dividend Yield	N/A	1.79%	2.59%	10.03%
P/E Ratio	11.35	23.11	282.28	24.66
Price / Sales	0.37	56.80	563.21	75.35
Price / Cash	6.00	32.53	28.60	46.71
Price / Book	1.36	6.29	10.96	6.07
Net Income	$9.62M	$151.15M	$3.49B	$347.99M
7 Day Performance	2.62%	0.94%	-0.63%	-0.44%
1 Month Performance	-0.64%	-3.52%	-5.23%	-4.81%
1 Year Performance	-33.27%	2.28%	62.07%	18.61%

Kewaunee Scientific Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
KEQU Kewaunee Scientific	1.006 of 5 stars	$36.56 +2.3%	N/A	-34.8%	$104.91M	$282M	11.35	1,231
PRE Prenetics Global	1.5992 of 5 stars	$18.26 -3.5%	$34.25 +87.6%	+133.0%	$319.43M	$92.39M	N/A	1	Gap Up
LAB Standard BioTools	3.5891 of 5 stars	$0.79 +2.6%	$1.35 +69.9%	-33.2%	$302.38M	$85.33M	3.97	620	Upcoming Earnings Short Interest Decrease
OPTX Syntec Optics	0.218 of 5 stars	$6.38 -10.6%	N/A	+281.9%	$287.60M	$28.08M	N/A	3	News Coverage High Trading Volume
MASS 908 Devices	2.2451 of 5 stars	$7.03 -1.4%	$12.00 +70.7%	+24.8%	$269.61M	$56.20M	N/A	60	Positive News Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:KEQU) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Kewaunee Scientific (KEQU) Competitors

KEQU vs. PRE, LAB, OPTX, MASS, and NAUT

How does Kewaunee Scientific compare to Prenetics Global?

Summary

How does Kewaunee Scientific compare to Standard BioTools?

Summary

How does Kewaunee Scientific compare to Syntec Optics?

Summary

How does Kewaunee Scientific compare to 908 Devices?

Summary

How does Kewaunee Scientific compare to Nautilus Biotechnology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KEQU vs. The Competition

Kewaunee Scientific Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Kewaunee Scientific (KEQU) Competitors

KEQU vs. PRE, LAB, OPTX, MASS, and NAUT

How does Kewaunee Scientific compare to Prenetics Global?

Which has more risk & volatility, KEQU or PRE?

Which has stronger earnings & valuation, KEQU or PRE?

Is KEQU or PRE more profitable?

Do analysts recommend KEQU or PRE?

Does the media favor KEQU or PRE?

Do institutionals and insiders have more ownership in KEQU or PRE?

Summary

How does Kewaunee Scientific compare to Standard BioTools?

Do analysts recommend LAB or KEQU?

Which has preferable earnings & valuation, LAB or KEQU?

Do institutionals and insiders hold more shares of LAB or KEQU?

Does the media refer more to LAB or KEQU?

Is LAB or KEQU more profitable?

Which has more risk & volatility, LAB or KEQU?

Summary

How does Kewaunee Scientific compare to Syntec Optics?

Is OPTX or KEQU more profitable?

Which has more risk and volatility, OPTX or KEQU?

Do analysts recommend OPTX or KEQU?

Do insiders and institutionals hold more shares of OPTX or KEQU?

Which has higher earnings and valuation, OPTX or KEQU?

Does the media refer more to OPTX or KEQU?

Summary

How does Kewaunee Scientific compare to 908 Devices?

Which has more risk & volatility, KEQU or MASS?

Which has higher earnings and valuation, KEQU or MASS?

Does the media prefer KEQU or MASS?

Do insiders & institutionals have more ownership in KEQU or MASS?

Is KEQU or MASS more profitable?

Do analysts rate KEQU or MASS?

Summary

How does Kewaunee Scientific compare to Nautilus Biotechnology?

Is NAUT or KEQU more profitable?

Which has more volatility and risk, NAUT or KEQU?

Do analysts rate NAUT or KEQU?

Which has preferable earnings and valuation, NAUT or KEQU?

Does the media favor NAUT or KEQU?

Do institutionals & insiders hold more shares of NAUT or KEQU?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KEQU vs. The Competition

Kewaunee Scientific Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools